公司資料
Vigil Neuroscience 股價、新聞與催化劑
- 股票代碼:
- VIGL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for VIGL.
公司概覽
業務概覽
Vigil Neuroscience is a neuroscience company focused on microglia biology and neurodegenerative disease. Its programs aim at immune pathways in the brain rather than traditional symptomatic therapies.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Vigil sits in specialty neuroscience biotechnology.
商業模式特徵
The business depends on translational data, target validation, and the potential to create a differentiated CNS franchise.
生技產業定位
Vigil is a platform CNS name whose valuation hinges on early clinical and mechanistic validation.
未來催化劑
- Vigil’s catalyst is VG-3927 and the rest of its microglia-focused neuroinflammation platform. The market will care about whether the biology can still produce a credible neurodegeneration story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。